Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) — Stock Price
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) is currently trading at Rs294.55 INR, down 9.19% today. Over the past 52 weeks, shares have ranged between Rs255.30 and Rs392.10. This page tracks Advanced Enzyme Technologies Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Advanced Enzyme Technologies Limited (ADVENZYMES) total market value.
Advanced Enzyme Technologies Limited (ADVENZYMES) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Advanced Enzyme Technologies Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Advanced Enzyme Technologies Limited Income Statement — Revenue, Profit & Earnings by Year
Advanced Enzyme Technologies Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs7.46 Billion | Rs6.37 Billion | Rs6.23 Billion | Rs5.41 Billion | Rs5.29 Billion |
| Cost of Revenue | Rs3.95 Billion | Rs3.30 Billion | Rs1.59 Billion | Rs1.32 Billion | Rs1.19 Billion |
| Gross Profit | Rs3.50 Billion | Rs3.07 Billion | Rs4.64 Billion | Rs3.98 Billion | Rs4.09 Billion |
| Research & Development | Rs14.20 Million | Rs8.75 Million | Rs216.68 Million | Rs216.59 Million | Rs193.73 Million |
| SG&A | Rs449.16 Million | Rs208.92 Million | Rs240.71 Million | Rs218.26 Million | Rs207.19 Million |
| Total Operating Expenses | Rs1.61 Billion | Rs1.49 Billion | Rs2.91 Billion | Rs1.43 Billion | Rs2.41 Billion |
| Operating Income | Rs1.89 Billion | Rs1.58 Billion | Rs1.73 Billion | Rs1.30 Billion | Rs1.71 Billion |
| EBITDA | Rs2.75 Billion | Rs2.27 Billion | Rs2.27 Billion | Rs1.79 Billion | Rs2.09 Billion |
| EBIT | Rs2.35 Billion | Rs1.91 Billion | Rs1.92 Billion | Rs1.44 Billion | Rs1.74 Billion |
| Interest Expense | Rs26.28 Million | Rs35.57 Million | Rs41.21 Million | Rs34.78 Million | Rs29.55 Million |
| Income Before Tax | Rs2.33 Billion | Rs1.87 Billion | Rs1.88 Billion | Rs1.40 Billion | Rs1.71 Billion |
| Income Tax Expense | Rs589.28 Million | Rs533.90 Million | Rs508.70 Million | Rs365.22 Million | Rs472.59 Million |
| Net Income | Rs1.69 Billion | Rs1.31 Billion | Rs1.33 Billion | Rs1.06 Billion | Rs1.20 Billion |
Advanced Enzyme Technologies Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Advanced Enzyme Technologies Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs18.39 Billion | Rs16.21 Billion | Rs15.35 Billion | Rs14.22 Billion | Rs12.68 Billion |
| Total Current Assets | Rs10.44 Billion | Rs8.80 Billion | Rs8.10 Billion | Rs7.21 Billion | Rs6.04 Billion |
| Cash & Equivalents | — | Rs667.50 Million | Rs717.48 Million | Rs368.43 Million | Rs821.61 Million |
| Short-term Investments | Rs5.84 Billion | Rs4.80 Billion | Rs4.34 Billion | Rs3.86 Billion | Rs1.08 Billion |
| Net Receivables | Rs1.45 Billion | Rs1.16 Billion | Rs999.88 Million | Rs1.01 Billion | Rs908.47 Million |
| Inventory | Rs1.77 Billion | Rs1.57 Billion | Rs1.48 Billion | Rs1.24 Billion | Rs1.21 Billion |
| Property, Plant & Equipment | — | Rs3.15 Billion | Rs3.07 Billion | Rs2.89 Billion | Rs2.72 Billion |
| Goodwill | Rs3.69 Billion | Rs3.33 Billion | Rs3.25 Billion | Rs3.21 Billion | Rs2.96 Billion |
| Total Liabilities | Rs1.56 Billion | Rs1.53 Billion | Rs1.64 Billion | Rs1.38 Billion | Rs1.27 Billion |
| Total Current Liabilities | Rs1.07 Billion | Rs967.55 Million | Rs1.06 Billion | Rs775.66 Million | Rs604.22 Million |
| Long-term Debt | Rs78.87 Million | Rs91.83 Million | Rs69.60 Million | Rs77.99 Million | Rs81.30 Million |
| Net Debt | Rs-839.22 Million | Rs-683.35 Million | Rs-664.43 Million | Rs-629.21 Million | Rs-2.33 Billion |
| Total Stockholder Equity | Rs16.32 Billion | Rs14.21 Billion | Rs13.24 Billion | Rs12.35 Billion | Rs10.89 Billion |
| Retained Earnings | Rs12.65 Billion | Rs11.53 Billion | Rs10.79 Billion | Rs10.02 Billion | Rs9.07 Billion |
Advanced Enzyme Technologies Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Advanced Enzyme Technologies Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs1.73 Billion | Rs1.49 Billion | Rs1.41 Billion | Rs1.40 Billion | Rs1.22 Billion |
| Capital Expenditures | Rs522.30 Million | Rs338.08 Million | Rs423.13 Million | Rs381.81 Million | Rs281.76 Million |
| Free Cash Flow | Rs1.20 Billion | Rs1.15 Billion | Rs990.56 Million | Rs1.02 Billion | Rs941.15 Million |
| Investing Cash Flow | Rs-923.39 Million | Rs-990.44 Million | Rs-646.49 Million | Rs-2.98 Billion | Rs-249.12 Million |
| Financing Cash Flow | Rs-679.45 Million | Rs-692.02 Million | Rs-592.38 Million | Rs-257.98 Million | Rs-273.75 Million |
| Dividends Paid | Rs-597.78 Million | Rs-590.30 Million | Rs-567.12 Million | Rs125.42 Million | Rs118.60 Million |
| Stock-Based Compensation | Rs48.60 Million | Rs34.46 Million | Rs30.31 Million | Rs0.00 | Rs0.00 |
| Depreciation | Rs400.93 Million | Rs365.56 Million | Rs352.42 Million | Rs350.29 Million | Rs349.83 Million |
| Change in Cash | Rs214.78 Million | Rs-195.24 Million | Rs173.31 Million | Rs-1.71 Billion | Rs754.36 Million |
Advanced Enzyme Technologies Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Advanced Enzyme Technologies Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Feb 06, 2026 | — | — | — |
| Nov 07, 2025 | — | — | — |
| Aug 08, 2025 | — | — | — |
| May 13, 2025 | 2.37 | 3.90 | -39.23% |
| Feb 08, 2025 | 3.36 | 4.00 | -16.00% |
| Nov 09, 2024 | — | — | — |
| May 11, 2024 | 3.88 | 3.80 | +2.11% |